Kumar, S. et al. 2024. A Real World Analysis of Safety and Efficacy of Nilotinib when Used as First Line and Beyond: Retrospective Single Centre Study Representing Largest Cohort of Indian Patients Treated with Nilotinib. Asian Pacific Journal of Cancer Biology. 9, 2 (May 2024), 137–147. DOI:https://doi.org/10.31557/apjcb.2024.9.2.137-147.